
Sign up to save your podcasts
Or
In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how it’s treated today, and where research is headed. Dr. Hoffmann shares insights on treatment goals, side effect management, and the importance of shared decision making. We also touch on emerging therapies—including CAR T-cell therapy and bispecifics—and end with a message of hope for those navigating life after a CLL diagnosis.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by AbbVie Inc., BeOne Medicines and Genentech, A Member of the Roche Group.
The post Partnering in Care: Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.
4.9
4545 ratings
In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how it’s treated today, and where research is headed. Dr. Hoffmann shares insights on treatment goals, side effect management, and the importance of shared decision making. We also touch on emerging therapies—including CAR T-cell therapy and bispecifics—and end with a message of hope for those navigating life after a CLL diagnosis.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by AbbVie Inc., BeOne Medicines and Genentech, A Member of the Roche Group.
The post Partnering in Care: Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.
10,326 Listeners
27,080 Listeners
12,901 Listeners
43,353 Listeners
14,899 Listeners
1,881 Listeners
9,285 Listeners
3,722 Listeners
4,129 Listeners
38,584 Listeners
41,407 Listeners
169 Listeners
7,127 Listeners
19,449 Listeners
708 Listeners